KV Pharmaceuticals Settles Derivative Suit

Law360 (April 9, 2008, 12:00 AM EDT) -- KV Pharmaceuticals Inc. will soon put its stock options backdating litigation behind it, after reaching a settlement with shareholders who brought a derivative suit against the company's directors.

St. Louis-based KV said Monday that it had reached a settlement in the derivative suit filed over the company's stock options granting practices. The company did not disclose the amount of the settlement, but said it expected insurance to cover the fees and costs associated with the case.

“Upon its finalization, the settlement of this litigation will be...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.